Related Experiment Video
Updated: Aug 6, 2026
Application of Laser Micro-irradiation for Examination of Single and Double Strand Break Repair in Mammalian Cells
Published on: September 5, 2017
Mitoquinone restores platelet production in irradiation-induced thrombocytopenia
Haley Ramsey1, Qi Zhang, Mei X Wu
1Department of Dermatology, Wellman Center for Photomedicine, Massachusetts General Hospital (MGH), Harvard Medical School (HMS) , Boston , MA and.
Abstract:
Myelodysplastic syndromes (MDS) are hallmarked by cytopenia and dysplasia of hematopoietic cells, often accompanied by mitochondrial dysfunction and increases of reactive oxygen species (ROS) within affected cells. However, it is not known whether the increase in ROS production is an instigator or a byproduct of the disease. The present investigation shows that mice lacking immediate early responsive gene X-1 (IEX-1) exhibit lineage specific increases in ROS production and abnormal cytology upon radiation in blood cell types commonly identified in MDS. These affected cell lineages chiefly have the bone marrow as a primary site of differentiation and maturation, while cells with extramedullary differentiation and maturation like B- and T-cells remain unaffected. Increased ROS production is likely to contribute significantly to irradiation-induced thrombocytopenia in the absence of IEX-1 as demonstrated by effective reversal of the disorder after mitoquinone (MitoQ) treatment, a mitochondria-specific antioxidant. MitoQ reduced intracellular ROS production within megakaryocytes and platelets. It also normalized mitochondrial membrane potential and superoxide production in platelets in irradiated, IEX-1 deficient mice. The lineage-specific effects of mitochondrial ROS may help us understand the etiology of thrombocytopenia in association with MDS in a subgroup of the patients.
Insights
Mice lacking the IEX-1 gene showed increased reactive oxygen species (ROS) in specific blood cells after radiation. Mitoquinone treatment reversed this, suggesting ROS’s role in myelodysplastic syndromes (MDS) related thrombocytopenia.
Area of Science:
- Hematology
- Mitochondrial Biology
- Molecular Genetics
Background:
- Myelodysplastic syndromes (MDS) are characterized by low blood counts and abnormal cell development.
- Mitochondrial dysfunction and increased reactive oxygen species (ROS) are observed in MDS, but their causal role is unclear.
- Immediate early responsive gene X-1 (IEX-1) function in MDS pathogenesis is not well understood.
Purpose of the Study:
- To investigate the role of IEX-1 in regulating ROS production and hematopoietic cell abnormalities.
- To determine if increased ROS contributes to thrombocytopenia in the context of MDS.
- To evaluate the therapeutic potential of mitochondria-targeted antioxidants in MDS-related cytopenias.
Main Methods:
- Utilized IEX-1 deficient mice to study lineage-specific responses to radiation.
- Assessed ROS production, cellular morphology, and mitochondrial function in hematopoietic cells.
- Administered mitoquinone (MitoQ), a mitochondria-specific antioxidant, to evaluate its effects on radiation-induced thrombocytopenia.
Main Results:
- IEX-1 deficient mice exhibited lineage-specific increases in ROS and abnormal cytology in bone marrow-derived cells post-radiation.
- B- and T-cells, with extramedullary maturation, were unaffected, indicating a lineage-specific effect.
- MitoQ treatment effectively reversed radiation-induced thrombocytopenia in IEX-1 deficient mice by reducing ROS and normalizing mitochondrial function in platelets and megakaryocytes.
Conclusions:
- Loss of IEX-1 leads to increased mitochondrial ROS in specific hematopoietic lineages, contributing to thrombocytopenia.
- Mitochondrial ROS plays a significant role in the etiology of thrombocytopenia associated with MDS in certain patients.
- MitoQ demonstrates therapeutic potential for managing MDS-related thrombocytopenia by targeting mitochondrial dysfunction.
